Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

After a 40-year search, a hormone controlling iron metabolism in mammals is finally identified

04.04.2002


Iron is vital for cells, because it catalyzes key enzyme reactions; it is also crucial for respiration, fixing atmospheric oxygen to hemoglobin in red blood cells. Iron deficiency can lead to severe anemia, with inadequate tissue oxygenation. An excess of iron is also toxic, as it facilitates the generation of free radicals that can attack the liver, heart and pancreas. This is the case in hereditary hemochromatosis, a genetic disorder which, in 80% of cases, is linked to a point mutation in the Hfe-1 gene, leading to excessive iron uptake by the intestinal tract. Hereditary hemochromatosis is very frequent in western countries, affecting one in 300 people. The body has no physiological mechanism for eliminating iron, and the only effective treatment for patients with hereditary hemochromatosis is bleeding, in some cases several times a week. These patients, and their doctors, are eagerly awaiting a breakthrough in our understanding of the mechanisms regulating iron metabolism, that might have therapeutic implications.



Dietary iron enters the body via cells known as enterocytes, that line the intestinal folds. Humoral signals are known to modulate how much iron these cells take up, according to the body`s internal stores. Yet, despite intense research over the last four decades, no-one had previously been able to identify these signals.

It is by chance that Gaël Nicolas, Sophie Vaulont and their coworkers came across such a signal while working on knock-out mice developed in their laboratory. The mice lacked a transcription factor known as USF2 (upstream stimulatory factor 2), thought to be involved in glucose metabolism. To their surprise, the team found that the mice had disorders similar to those of patients with hereditary hemochromatosis, namely premature ageing of the pancreas and liver, which take on an abnormal brown color - a sign of iron accumulation. Further tests indeed showed that the animals had a form of hemochromatosis. Intrigued, the team created a subtractive RNA bank in order to determine whether any other genes were abnormally expressed in their model. This was effectively the case. One abnormally expressed gene was found to correspond to a recently identified sequence of 25 amino acids found in members of an antimicrobial peptide family called the defensins. The peptide in question - hepcidin - is produced by the liver and secreted into the bloodstream. Hepcidin has a degree of antimicrobial activity, but Axel Kahn, Sophie Vaulont and their colleagues at Bichat Hospital in Paris believe that it acts essentially as a true hormone, inhibiting iron uptake by intestinal cells; they also believe that when hepcidin dysfunctions the body has no way of limiting iron absorption into the bloodstream.


To test this hypothesis, the team first checked that iron levels were normal in a transgenic mouse model, produced in another laboratory, that lacks USF2 but has an intact hepcidin gene. Then they went on to create transgenic mice whose livers overproduced hepcidin, expecting them to develop anemia. In the event, almost all the new-born animals were smaller than normal, had very pale skin and no hair, were profoundly anemic, and died within hours of birth - unless they received an injection of iron. (Some animals producing less hepcidin were less severely anemic and survived without treatment.)

This discovery opens up exciting therapeutic and diagnostic perspectives in diseases due to abnormal iron homeostasis. Therefore, a patent application has been filed by INSERM and the inventors. One short-term possibility is a diagnostic test based on serum hepcidin measurement. In the longer term, the development of hepcidin agonists and antagonists may well transform the treatment of these frequent and potentially severe disorders.

Nathalie Christophe | alphagalileo

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>